• LAST PRICE
    3.1000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 3.1000
  • Day Range
    ---
  • 52 Week Range
    Low 0.8000
    High 3.5400
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.29
TimeVolumeZEOX
09:32 ET2503.03
10:18 ET50003.08
10:20 ET5693.1075
10:40 ET1003.2225
11:14 ET2003.25
11:32 ET37483.05
11:34 ET1003
11:38 ET18033.05
11:57 ET4103.1125
12:12 ET5913.2175
12:51 ET7503.28
01:02 ET68503.27
01:38 ET2503.1
Data delayed at least 15 minutes.

Industry Peers

Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesZEOX
ZEO ScientifiX Inc
20.4M
-4.4x
---
United StatesCOSM
Cosmos Health Inc
17.7M
-0.3x
---
United StatesTRFED
Polomar Health Services Inc
7.1M
-8.7x
---
United StatesEXDW
Exceed World, Inc.
9.8M
-12.5x
---
United StatesHEWA
HealthWarehouse.com Inc
4.7M
-3.1x
---
United StatesSSY
SunLink Health Systems Inc
5.6M
-2.4x
---
As of 2024-11-22

Company Information

Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company. It develops biological therapeutics for the treatment of degenerative diseases and regenerative medicine. Its products are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent and an autologous non-manipulated biologic containing the nanoparticle fraction from a patient’s own peripheral blood (RAAM Products). Its RAAM Products and related services are principally used in the health care industry, administered by doctors and clinics. The Company’s product, Zofin (Organicell Flow), is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs. Patient Pure X, its autologous product, is a non-manipulated biologic containing the nanoparticle fraction from a patient’s own peripheral blood.

Contact Information

Headquarters
3321 College Avenue, Suite 246DAVIE, FL, United States 33328
Phone
305-370-0482
Fax
---

Executives

Interim Chief Executive Officer, Chief Financial Officer, Director
Ian Bothwell
Independent Non-Executive Vice Chairman of the Board
Chuck Bretz
Chief Medical Officer, Director
George Shapiro
Independent Director
S. Jerry Glauser
Independent Director
Gurvinder Singh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
---
Revenue (TTM)
---
Shares Outstanding
---
ZEO ScientifiX Inc does not pay a dividend.
Beta
---
EPS
---
Book Value
---
P/E Ratio
-4.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.